Table 3.
Characteristics of the participants during the 8th week of the dietary intervention (ITT analysis).
| Variable | Control (n = 30) |
Plain Yogurt (n = 28) |
Enriched Yogurt (n = 30) |
p between-group |
|---|---|---|---|---|
| BMI (kg/m2) | 26.9 (23.4, 30.2) | 29.0 (25.4, 31.1) | 27.2 (24.8, 29.5) | 0.338 |
| LDL-C (mg/dL) | 130.3 (38.0) | 131.4 (27.8) | 136.5 (34.9) | 0.751 |
| PAF-AH (pmol/mg/min) | 67.38 (46.07, 86.46) | 50.13 (34.87, 74.81) | 55.0 (35.72, 75.30) | 0.148 |
| LpPLA2 (nmol/mL/min) | 27.13 (23.54, 31.84) | 29.15 (24.44, 32.41) | 26.23 (21.97, 30.49) | 0.300 |
| PAF-CPT (pmol/mg/min) | 183.87 (144.25, 227.20) | 151.81 (104.18, 201.85) | 146.44 (130.23, 190.51) | 0.094 |
| Lyso-PAF ATC (pmol/mg/min) | 117.27 (64.92, 176.40) | 87.76 (68.77, 126.33) | 78.60 (55.73, 108.04) | 0.106 |
| Lyso-PAF ATE (pmol/mg/min) | 44.13 (34.10, 74.10) | 56.86 (41.45, 83.58) | 55.21 (38.85, 70.83) | 0.601 |
| LpPLA2-to-LDL ratio | 0.20 (0.17, 0.25) | 0.23 (0.20, 0.26) | 0.19 (0.17, 0.22) | 0.049 |
Categorical variables are presented as absolute frequencies (n); continuous variables are presented as mean (standard deviation) if normally distributed or as median (25th, 75th percentiles) if non-normally distributed; one-way analysis of variance (ANOVA) or Kruskal–Wallis tests were used to compare groups for continuous variables with normal and non-normal distribution, respectively; significance (α) level was set to 0.05. BMI: body mass index; LDL-C: low-density lipoprotein cholesterol; LpPLA2: lipoprotein-associated phospholipase A2; Lyso-PAF ATC: lyso-platelet-activating factor acetyltransferase in the presence of Ca2+; Lyso-PAF ATE: lyso-platelet-activating factor acetyltransferase in the presence of EDTA; PAF-AH: platelet-activating acetyl-hydrolase; PAF-CPT: platelet-activating factor-cholinephosphotransferase.